scholarly journals Preparation of Multifunctional Dopamine-Coated Zerovalent Iron/Reduced Graphene Oxide for Targeted Phototheragnosis in Breast Cancer

Nanomaterials ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. 1957
Author(s):  
Chia-Hua Lin ◽  
Yi-Chun Chen ◽  
Pin-I. Huang

The present study aimed to develop a multifunctional nanoparticle platform with properties that are beneficial in imaging, targeting, and synergistic cancer phototherapy. To this end, we synthesized novel nanoparticles composed of polydopamine, nano zero-valent iron (nZVI), and reduced graphene oxide (rGO). We immobilized nZVI on the surface of GO (nZVI/GO), then further modified nZVI/GO with dopamine to form polydopamine-conjugated nZVI/rGO (nZVI/rGO@pDA). Because nZVI/rGO@pDA absorbs near infrared radiation (NIR) and binds biomolecules of cancer cells, this platform is highly efficacious in photothermal and photodynamic cancer therapy and enables specific targeting of breast cancer cells. Use of nZVI/rGO@pDA at a low concentration (10 μg/mL) resulted in irreversible damage to MCF-7 cells under NIR irradiation (808 nm) without inducing cytotoxic effects in normal cells. Furthermore, nZVI/rGO@pDA showed high sensitivity in magnetic resonance imaging (MRI), comparable to nZVI@pDA, even at low concentration. Monitoring the treatment response through evaluation of MRI signal intensity of nZVI/rGO@pDA in phototherapeutic therapy revealed that the novel material combines the advantages of nZVI, rGO, and pDA to provide specific targeting capabilities, excellent biocompatibility, and cancer phototherapeutic and tumor imaging abilities. Thus, this platform offers great potential in terms of imaging and therapeutic effects in phototherapy treatment for breast cancer.

2018 ◽  
Vol 42 (15) ◽  
pp. 13157-13168 ◽  
Author(s):  
Hossein Golzar ◽  
Fatemeh Yazdian ◽  
Mohadeseh Hashemi ◽  
Meisam Omidi ◽  
Dorsa Mohammadrezaei ◽  
...  

Conjugation of Herceptin to the surface of an optimized rGO-PLL/AgNP nanohybrid to achieve an efficient targeted DDS against Her2 positive breast cancer cells.


ACS Omega ◽  
2021 ◽  
Author(s):  
Syed Farooq Adil ◽  
Mohammed Rafi Shaik ◽  
Fahd A. Nasr ◽  
Ali S. Alqahtani ◽  
Mohammad Z. Ahmed ◽  
...  

2021 ◽  
Vol 22 (22) ◽  
pp. 12593
Author(s):  
Rafał Krętowski ◽  
Agata Jabłońska-Trypuć ◽  
Marzanna Cechowska-Pasko

Breast cancer is the most common cancer diagnosed in women, however traditional therapies have several side effects. This has led to an urgent need to explore novel drug approaches to treatment strategies such as graphene-based nanomaterials such as reduced graphene oxide (rGO). It was noticed as a potential drug due to its target selectivity, easy functionalisation, chemisensitisation, and high drug-loading capacity. rGO is widely used in many fields, including biological and biomedical, due to its unique physicochemical properties. However, the possible mechanisms of rGO toxicity remain unclear. In this paper, we present findings on the cytotoxic and antiproliferative effects of rGO and its ability to induce oxidative stress and apoptosis of breast cancer cell lines. We indicate that rGO induced time- and dose-dependent cytotoxicity in MDA-MB-231 and ZR-75-1 cell lines, but not in T-47D, MCF-7, Hs 578T cell lines. In rGO-treated MDA-MB-231 and ZR-75-1 cell lines, we noticed increased induction of apoptosis and necrosis. In addition, rGO has been found to cause oxidative stress, reduce proliferation, and induce structural changes in breast cancer cells. Taken together, these studies provide new insight into the mechanism of oxidative stress and apoptosis in breast cancer cells.


2015 ◽  
Vol 55 ◽  
pp. 482-489 ◽  
Author(s):  
Shadie Hatamie ◽  
Omid Akhavan ◽  
Sayed Khatiboleslam Sadrnezhaad ◽  
Mohammad Mahdi Ahadian ◽  
Mandar M. Shirolkar ◽  
...  

2021 ◽  
Vol 3 ◽  
pp. 100024
Author(s):  
J.U. Halpegama ◽  
P.M.C.J. Bandara ◽  
L. Jayarathna ◽  
A. Bandara ◽  
Chen-Yu Yeh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document